Reye's syndrome: plasma-induced alterations in mitochondrial structure and function.
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000481:Allantoin / Q000097:blood / Q000494:pharmacology*; D000818:Animals; D002118:Calcium / Q000097:blood / Q000494:pharmacology*; D004533:Egtazic Acid / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism*; D009243:NAD / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D051381:Rats; D012202:Reye Syndrome / Q000097:blood*; D012430:Ruthenium Red / Q000494:pharmacology; D014527:Uric Acid / Q000494:pharmacology
D009243:NAD; D012430:Ruthenium Red; D014527:Uric Acid; D000481:Allantoin; D004533:Egtazic Acid; D000244:Adenosine Diphosphate; D002118:Calcium